Atrium Therapeutics(RNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RNA Atrium Therapeutics

Not Yet Opened 08-27 16:00:00 EDT

13.98

+0.13

+0.94%

盘后14.58

+0.60+4.29%

19:30 EDT

High14.09	Low13.59	Vol120.56K
Open13.78	D1 Closing13.85	Amplitude3.60%
Mkt Cap239.14M	Tradable Cap219.78M	Total Shares17.11M
T/O1.68M	T/O Rate0.77%	Tradable Shares15.72M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RNA","market":"US","secType":"STK","nameCN":"Atrium Therapeutics","latestPrice":13.98,"timestamp":1787860800000,"preClose":13.85,"halted":0,"volume":120562,"hourTrading":{"tag":"盘后","latestPrice":14.58,"preClose":13.98,"latestTime":"19:30 EDT","volume":1123,"amount":16376.2677,"timestamp":1787873402802,"change":0.6,"changeRate":0.042918,"amplitude":0.144492},"delay":0,"changeRate":0.00938628158844771,"floatShares":15721000,"shares":17105600,"eps":-3.857827,"marketStatus":"Not Yet Opened","change":0.13,"latestTime":"08-27 16:00:00 EDT","open":13.78,"high":14.09,"low":13.5916,"amount":1679880.16469,"amplitude":0.035986,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.857827,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787904000000},"marketStatusCode":0,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":13.85,"postHourTrading":{"tag":"盘后","latestPrice":14.58,"preClose":13.98,"latestTime":"19:30 EDT","volume":1123,"amount":16376.2677,"timestamp":1787873402802,"change":0.6,"changeRate":0.042918,"amplitude":0.144492},"volumeRatio":0.680399,"impliedVol":0.1535,"impliedVolPercentile":0.2},"requestUrl":"/m/hq/s/RNA/wiki","defaultTab":"wiki","newsList":[{"id":"2662701947","title":"Korro to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701947","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662701947?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:00","pubTimestamp":1787828400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Korro, Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA) platform to","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351890/0/en/korro-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4588","BK4585","BK4505","RNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759663","title":"Circio bolsters board as it advances circular RNA gene therapy platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759663?lang=en_us&edition=fundamental","pubTime":"2026-08-26 01:07","pubTimestamp":1787677640,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) has issued an announcement. Circio Holding ASA has strengthened its board of directors as it enters a new development p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-bolsters-board-as-it-advances-circular-rna-gene-therapy-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-bolsters-board-as-it-advances-circular-rna-gene-therapy-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","TBXU","BK4585","BK4139","IBBQ","BK4588","BK4505","CNCR","GNOM","LFSC","RNA","FBT","SYNB","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661223158","title":"Press Release: Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and Eur40.25 Million PIPE Financing from New and Existing Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661223158","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661223158?lang=en_us&edition=fundamental","pubTime":"2026-08-24 14:00","pubTimestamp":1787551200,"startTime":"0","endTime":"0","summary":"--  Definitive share purchase agreement signed for the acquisition of 100%. of Etherna Immunotherapies NV , and the related contribution. agreement, based on an enterprise value of EUR30 million, to be settled. through a combination of a cash consideration and a share consideration. --  EUR40.25 million PIPE financing successfully priced with support from. new and existing investors, to finance the cash consideration of the. Acquisition and support the development of the combined company. --  Shareholder approval of the Contributions, at an extraordinary general. meeting to be convened for that purpose, with approval already secured. representing more than 70% of the voting rights of the Company. --  The Acquisition marks a major milestone in Valerio's strategy to build. a leading platform in the development of next-generation precision-guided","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4585","PIPE","BK4588","RNA","ISBC","BK4139","BK4505","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661948882","title":"BioNTech’s New HIV RNA Vaccine Trial: What Investors Should Watch Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661948882","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661948882?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:33","pubTimestamp":1787330027,"startTime":"0","endTime":"0","summary":"Biontech Se Sponsored Adr ($BNTX) announced an update on their ongoing clinical study. The study, officially titled “A Randomized, Placebo-controll...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biontechs-new-hiv-rna-vaccine-trial-what-investors-should-watch-now?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biontechs-new-hiv-rna-vaccine-trial-what-investors-should-watch-now?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4588","BK4505","BK4139","BK4211","BK4535","RNA","BK4568","IE0009354923.USD","BNTX","ISBC","BK4548","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258925","title":"Brii Biosciences Narrows Interim Loss as HBV and RNA Pipelines Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258925","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258925?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:07","pubTimestamp":1787267244,"startTime":"0","endTime":"0","summary":"An announcement from Brii Biosciences Limited ( ($HK:2137) ) is now available. Brii Biosciences Limited reported unaudited interim results for the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/brii-biosciences-narrows-interim-loss-as-hbv-and-rna-pipelines-advance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/brii-biosciences-narrows-interim-loss-as-hbv-and-rna-pipelines-advance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4505","BK4139","RNA","BK4588","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661823025","title":"Atrium Therapeutics Awards New Hire Stock Options for 11,000 Shares at $13.48 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2661823025","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661823025?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:24","pubTimestamp":1787264694,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics awards new hire stock options for 11,000 shares at $13.48 eachAtrium Therapeutics issued inducement equity awards on Aug. 20, 2026 to one newly hired non-executive employee.Grant i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLbCy9Hp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4588","BK4585","IE0009354923.USD","BK4139","RNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661304002","title":"Atrium Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661304002","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661304002?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:24","pubTimestamp":1787264647,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUA3F0TJ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","BK4588","BK4585","RNA","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660678238","title":"Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2660678238","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660678238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:30","pubTimestamp":1787236225,"startTime":"0","endTime":"0","summary":"FACTBOX-Pharma sector doubles down on AI amid hopes of slashing costs, timelinesAug 20 (Reuters)-Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4N44H10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1691799644.USD","IE00BMPRXQ63.HKD","LU2247934214.USD","LU2125909759.SGD","LU0289941410.SGD","BK4576","LU0070302665.USD","LU0963555726.SGD","LU1863844665.USD","LU1674673691.USD","LU0315179316.USD","LU0889565916.HKD","LU0321505439.SGD","LU0061475181.USD","LU0354030438.USD","TEK","LU1153585028.USD","LU2413666699.HKD","SGXZ57979304.SGD","LU1430594728.SGD","IE0004445239.USD","SG9999014906.USD","LU1121112475.USD","LU1232071149.USD","IE00BN29S564.USD","CLSE","LU0098860793.USD","MSFY","LU0128525689.USD","LU1989773731.SGD","SGXZ81514606.USD","LU0211331839.USD","LU1551013342.USD","LU2404859667.USD","LU1960683339.HKD","SG9999018865.SGD","LU1720051017.SGD","EKG","LU1582986359.USD","LU0823434740.USD","LU0997586432.USD","LU2237443895.HKD","LU2272731782.SGD","NVDX","LU0314109678.HKD","LU1046421795.USD","SG9999000418.SGD","LU2279689827.SGD","SG9999004303.SGD","IYH","LU2237443382.USD","LU2750360997.AUD","LU2471134796.USD","LU1069344957.HKD","LU2543165471.USD","LU1202635105.USD","LU0256863902.USD","MRK","LU2539964713.USD","TMED","LU1481600234.SGD","LU0203202063.USD","BMY","SG9999013999.USD","LU2322448791.USD","MSFW","LU2168564222.USD","IE00B3M56506.USD","LU0726765562.USD","ROM","LU0689472784.USD","LU0976567544.SGD","LU1974910355.USD","LU0757359368.USD","LU2065170008.USD","BK4574","LU1941712264.USD","LU0225283273.USD","LU0310799852.SGD","LU0648000940.SGD","IE00BYQQ9H92.USD","LU1670711040.USD","LU2023250330.USD","BK4551","LU1074936037.SGD","LU1235295455.SGD","LU0140636845.USD","LU0823416689.USD","LU0964807845.USD","LU1983260115.SGD","BMED","LU0154236417.USD","LU0690374615.EUR","LU0690374961.EUR","IE0002270589.USD","LU2148611432.USD","LU2491049909.HKD","LU1880407215.USD","LU2462157665.USD","IE00BFMHRM44.USD","ELIS","IE0000B7K699.USD","IXN","LU2362540622.SGD","LU0345777147.USD","LU0056508442.USD","LH","TYLG","LU0784385170.HKD","LU1267930227.SGD","LU1868837300.USD","LU1069347547.HKD","LU0308772762.SGD","BK4527","LU0823434583.USD","LU0320765489.SGD","LU2506952170.USD","LU0820561909.HKD","LU1951198990.SGD","IE00BKDWB100.SGD","IETC","BK4532","LU2063271972.USD","LU0345770308.USD","BK4579","LU0757432116.USD","LU1697837992.HKD","IE00BJT1NW94.SGD","LU1093756168.USD","SGXZ31699556.SGD","LU0882574139.USD","LU1861215975.USD","SG9999001176.SGD","LU0171293334.USD","LU0203345920.USD","LU0942090050.USD","LU1429558221.USD","MSFO","SOXQ","SLP","ESUM","LU1506573853.SGD","LU0719512351.SGD","BK4585","BK5011","SGXZ23171101.USD","LU1868837136.USD","LU0323591593.USD","LU0476273544.USD","BK4503","LU2433249047.HKD","GOU","LU2023250504.SGD","FCOM","LU0795875169.SGD","LU1551013425.SGD","IE00BKVL7J92.USD","LU1823568750.SGD","LU0266013472.USD","LU2506951958.HKD","LU2092627202.USD","INCY","LU0456855351.SGD","LU1066051225.USD","LU2764263039.SGD","TDIV","LU1813983027.USD","LU1496350502.SGD","LU1803068623.USD","LU0787776722.HKD","LU2294711713.HKD","LU1301847155.USD","LU0122379950.USD","LU0960981461.USD","IE00B3PB1722.GBP","BK4612","IE00BN8TJ469.HKD","LU0251131958.USD","LU0889566641.SGD","LU2047632596.USD","LU2361044865.SGD","LU0081259029.USD","LU2360107168.USD","LU0225771236.USD","LU0079474960.USD","IE00BJTD4N35.SGD","LU0444973449.USD","LU1019632923.USD","LU1699723380.USD","LU2896262040.SGD","LU1564329115.USD","IE00BVYPNW00.USD","LU0957799991.USD","LU1868836757.USD","LU1582987597.SGD","LU1934455194.USD","LU0553294199.USD","LU1935042215.USD","BK4139","LU2931357623.SGD","XDAT","03165","LU0095938881.EUR","LU1951200564.SGD","LLYX","LU0048584097.USD","RSPS","LU2129689514.USD","LU1645745479.HKD","LU1093756325.SGD","LU1815333072.USD","HK0000306685.HKD","LU0082616367.USD","LU1196500208.SGD","NULC","LU0094547139.USD","LU0738911758.USD","LU0072913022.USD","LU0326950275.SGD","LU1804176565.USD","JGRO","LU0174119429.USD","LU2764263203.CNY","LU1929549753.HKD","IE00BFSS7M15.SGD","LU0640476718.USD","LU2355687059.USD","XLC","IE0004086264.USD","LU0786609619.USD","LU2290526834.HKD","07388","IE00BQXX3F31.USD","LU0965508806.USD","NVIW.SI","LU0857590862.USD","LU1941712348.USD","LU0494093205.USD","IE0009355771.USD","IE000BZT7R73.USD","LU2506951875.HKD","LU2357627491.SGD","IE0008369823.USD","LU0444971666.USD","LU1821325948.USD","LU0820561818.USD","LU0289739699.SGD","LU0889565080.SGD","LU1829250122.USD","LU1201861249.SGD","LU2471134952.CNY","LU1732799900.SGD","LU0096362180.USD","LU1280957306.USD","IE0009356076.USD","GOOP","BK4598","LU0472753341.HKD","LU1261432733.SGD","LU2326559502.SGD","IE00BKPKM643.USD","LU0052756011.USD","GOOGL","IE0008368742.USD","LU1894683348.USD","LU2092937221.SGD","LU2746668461.USD","METV","BK4614","SG9999003800.SGD","NVDL","LU2271345857.HKD","BK4505","LU0511384066.AUD","LU0985481810.HKD","LU0124676726.USD","LU0345768153.USD","LU2023250843.SGD","LU2089283258.USD","IE00B4JS1V06.HKD","LU1487256676.USD","SOXX","IE00B19Z8W00.USD","LU1934455863.HKD","GDOC","BK4566","LU0097036916.USD","LU1732800096.USD","LU2237443465.HKD","LU1226287529.USD","LU1127390331.HKD","LU0149725797.USD","LU1236620750.USD","LU1291159041.SGD","AIPI","LU2114397693.USD","LU0208291251.USD","LU1316542783.SGD","LU2265009873.SGD","LU0198837287.USD","BK4134","IE00BQXX3C00.GBP","LU0234570918.USD","LU0210533765.USD","IE00B42XCP33.USD","LU0997586515.USD","LU1674673428.USD","SMH","LU0306806265.USD","GB00B4LPDJ14.GBP","MSFD","HK0000304805.HKD","IE0001KFT4U8.USD","LU0170899867.USD","BK4097","LU0276348264.USD","LU0994945656.USD","LU1803068979.SGD","SOXY","LU1861127337.USD","DIPS","SG9999015358.SGD","LU2362541513.USD","LU2471134523.USD","LU0289739343.SGD","LU0708994859.HKD","LU1267930573.SGD","PJP","LU0080751232.USD","LU1839511570.USD","LU2360106947.USD","LU2462591350.SGD","SG9999014542.SGD","NVDG","LU2322448957.HKD","LU0985320562.USD","LU0029864427.USD","SG9999011175.SGD","LU0575583348.USD","LTL","LU0347712357.USD","LU0545562505.USD","BK4592","LU1355424745.HKD","LU2237443622.USD","IE00BK4W5L77.USD","LU3102509885.SGD","LU1226288170.HKD","ANV","LU0114720955.EUR","LU0342679015.USD","LU0943347566.SGD","LU1226287875.USD","LU1226288253.USD","LU0385154629.USD","LU2249611893.SGD","IE0009354923.USD","KVUE","SG9999001424.SGD","LU0795875086.SGD","LU1923623000.USD","TRUC","VGT","LU0353189763.USD","LU0077335932.USD","LU2028103732.USD","LU2250418816.HKD","BK4548","LU0757359954.USD","LU1303367103.USD","MSFL","IE00BMPRXN33.USD","HK0000304797.USD","LU0109394709.USD","LU1481599808.USD","EFIV","LU2089985449.USD","LU2420271590.USD","LU1008478684.HKD","2NVD.UK","LU2487616109.SGD","LU0861579265.USD","LU0950375773.USD","LU1852331112.SGD","LU2275660780.HKD","LU1721428933.USD","LU2430703251.USD","LU1340139317.AUD","LU0187121727.USD","LU0067412154.USD","LU0210536198.USD","NVDA","LU1815336760.USD","LU2168563687.JPY","SG9999014567.USD","LU2092937148.SGD","LU1057294990.SGD","MHIP","RNA","GOOW","LU2129689431.USD","LU2452424414.USD","LU1720051108.HKD","HK0000320223.HKD","LU2347655156.SGD","SG9999014898.SGD","SG9999002232.USD","LU2242646821.SGD","BK4183","LU1145028129.USD","LU1496350171.SGD","LU2720916845.USD","LU0868494617.USD","IE00B5TLWC47.USD","LU0265550946.USD","LU2125909916.SGD","HK0000914660.USD","BK4573","LU1242518857.USD","LU2125154935.USD","MSFU","LU0107464264.USD","LU1201861165.SGD","SG9999004220.SGD","LU2505996509.AUD","LU0526926950.USD","LU0061474960.USD","LU2552382132.HKD","LU2471134879.HKD","IE000ITXATA3.USD","SHOC","CHAT","LU0158827948.USD","LU0310800379.SGD","GAMR","IE000KEQY171.SGD","LU2458330169.SGD","BK4577","LU0477156797.USD","LU0061474705.USD","LU0211326839.USD","IE00BDRTCR15.USD","LU1807302812.USD","IQV","IE0002141913.USD","LU0234572021.USD","LU1228905540.USD","LU2286300806.USD","LU0965509010.AUD","LU2592432038.USD","SG9999001176.USD","SNPE","IE00B7SZLL34.SGD","BK1617","SGXZ99366536.SGD","LU0006306889.USD","LU0320765059.SGD","LU0057025933.USD","LU2087625088.SGD","GXPC","USXF","HK0000320264.USD","IE00B19Z8X17.USD","LU0211326755.USD","LU0069063385.USD","LU1951186391.HKD","LU2065169927.USD","LU0871640123.AUD","LU0274383776.USD","PFE","FHLC","LU1236620834.HKD","WISE","SG9999002224.SGD","SNVDAmain","LU0345769631.USD","LU1435385759.SGD","LU2023251221.USD","LU2293690082.USD","MSFT","LU1181866309.USD","LU1814569148.SGD","LU2360032135.SGD","LU0528227936.USD","IE00BKPKM429.USD","IE00B2B36J28.USD","KD","LU1564329461.SGD","BK4605","CHPX","MSFX","LU1917777945.USD","LU0345769128.USD","LU0390134368.USD","JNJ","LU1633808545.USD","NVDD","BK4528","LU1868836591.USD","LU1244550577.SGD","LU0171276677.USD","IE00BLSP4239.USD","SDGR","NVD3.UK","XLV","LU2168564495.EUR","LU1880407132.USD","LU2324357040.USD","IE000Q6AESB8.SGD","LU1244550221.USD","BK4141","LU0127658192.USD","LU0130517989.USD","THNR","WDNA","LU2860962120.EUR","LU0323240290.USD","NVD2.UK","LU1153584641.USD","LU0138981039.USD","LU0823421333.USD","SMHX","LU0157215616.USD","LU1152091754.HKD","IE00BWXC8680.SGD","LU2133065610.SGD","LU2360106780.USD","LU0312595415.SGD","IE00BD6J9T35.USD","LU1037948897.HKD","LU1273509221.SGD","LU0128526141.USD","LU1670627923.USD","LU2102340556.USD","LU2125909247.SGD","LU0965509283.SGD","LU1059921491.USD","LU2237438978.USD","LU2362541273.HKD","IE0034235188.USD","LU0642271901.SGD","LU0742534661.SGD","LU0823414478.USD","LU1629891620.HKD","LU2237443549.SGD","LU1196032939.SGD","LU0175139822.USD","IE00BJJMRZ35.SGD","BK4167","LU2210149790.SGD","LU1778281490.HKD","LU0348723411.USD","LU2272731865.HKD","IE0005OL40V9.USD","BK4121","NVDS.UK","LU0053666078.USD","LU2237957811.SGD","LU1712237335.SGD","3NVD.UK","LU2054465674.USD","LU2041044095.USD","LU0321505868.SGD","SG9999014559.SGD","LU0251132253.USD","LLYZ","SG9999017495.SGD","LU0289960550.SGD","LU0130102774.USD","LU1989772923.USD","LU2087621335.USD","LU0672654240.SGD","LU1035773651.USD","LU0889565833.HKD","LU1989764664.SGD","LU2125909593.SGD","LU2417539215.USD","LU0689626769.HKD","LU1988902786.USD","LU1334329650.SGD","IE0003U64NQ7.SGD","IE0034235303.USD","LU2125154778.USD","LU2211815571.USD","LU0792757196.USD","LU1880398554.USD","LU2602419157.SGD","BK4599","LU0251142724.SGD","LU2403377893.USD","LU1328277881.USD","IE00BFXG0V08.USD","GGLL","AGOX","IE00BQXX3D17.EUR","LU1116320901.HKD","TRUH","IE00B5949003.HKD","LU0316494557.USD","LU2213496289.HKD","IE00BJJMRY28.SGD","LU2430703095.HKD","LU0265550359.USD","LU0882574055.USD","LU2506952097.USD","LU0972486137.USD","CANC","LU0203347892.USD","BK4559","SGXZ44715902.SGD","GGLS","IE00BYXW3230.USD","LU2461242641.AUD","CURE","LU0920840948.USD","JDOC","CMAG","AGNG","IE00BLSP4452.SGD","LU1670710661.SGD","LU0724617625.USD","LU1066051498.USD","LU0158827781.USD","LU0879622024.SGD","LU0047473722.SGD","LU0957791311.USD","TTEQ","LU2129689605.HKD","LU1221951129.SGD","LU0477156953.USD","IGV","LU0267386448.USD","LU0661504455.SGD","LU2098885051.SGD","LU1078025761.USD","LU2168564065.EUR","NVDO","IE00B031HY20.USD","LU1037948541.HKD","BK4543","LU1923622291.USD","LU0912757837.SGD","LU1366333091.USD","LU0501845795.SGD","LU2552382215.SGD","LU1043141396.HKD","IE00BSNM7G36.USD","LU1585245621.USD","BK4549","IE00BZ1G4Q59.USD","LU2237443978.SGD","BK4516","IE00B4YYXB79.USD","IE00B66KJ199.SGD","LU2491050154.USD","LU0823414551.USD","LLY","BK4550","LU0417517546.SGD","LFGY","LU1989772840.SGD","LU2456880835.USD","NVDQ","LU1226287792.SGD","LU0823417653.USD","IE00B5MMRT66.SGD","LU1023059063.AUD","LU0058720904.USD","PPH","IE0009G5SDU7.USD","LU0979878070.USD","SG9999015341.SGD","MEDX","CNEQ","VOX","LU1015430645.USD","LU0496365809.HKD","LU0823417737.USD","IE00B19Z4B17.USD","LU0395794307.EUR","LU2458330243.SGD","SKYY","GOOX","LU2361045086.USD","NVDU","LU2242650005.HKD","LU0354030511.USD","LU2394011477.USD","LU2097344431.USD","LU2236285917.USD","LU2473716301.USD","LU1989771016.USD","LU1548497426.USD","ESLG","LU3187612489.SGD","IE00B19Z3B42.SGD","LU0887340254.USD","NVDY","LU1670710588.SGD","LU2244417387.USD","GB00BDT5M118.USD","LU0128525929.USD","LU1979441026.SGD","LU1923622614.USD","LU1235294995.USD","IE00BJTD4V19.USD","BK1141","GB00B4QBRK32.GBP","LU0784385840.USD","SG9999015978.USD","LU1791710400.SGD","SGXZ51526630.SGD","LU1934455277.USD","GOOY","LU0969580561.USD","LU1642822529.SGD","LU0323239441.USD","LU1162221912.USD","BK4588","LU2191332357.HKD","IE00BBT3K403.USD","NVD","LU2468319806.SGD","LU0289961442.SGD","HK0000306701.USD","BK4525","GNMX","IE00B543WZ88.USD","LU0823399737.USD","LU0949170426.SGD","LU2089984988.USD","LU0072461881.USD","BK4504","VT","LU2746668974.SGD","LU0545039389.USD","BK4534","LU1046234339.USD","LU0345774391.USD","BK1521","BK4530","LU2112291526.USD","LU0426412945.USD","LU0211327993.USD","LU0225284248.USD","LU0310800965.SGD","LU1267930730.SGD","LU1670628061.USD","LLII","BK4567","IE000MB6IJN5.SGD","LU0820562030.AUD","IE00BZ08YT58.USD","LU2999663052.SGD","LU2272731600.USD","IE00B3T34201.USD","IE00BFXG1179.USD","LU1043141123.HKD","LU2954938101.SGD","LU1582986433.USD","LU0109391861.USD","LU1267930813.SGD","LU0345774631.USD","LU1914381329.SGD","LU1670711123.USD","LU1992135472.HKD","IE00B19Z3581.USD","XLK","LU2404859741.USD","IE00B1BXHZ80.USD","IE000YTNTUN2.SGD","IE00BGHQF631.EUR","LU2596442595.SGD","BK4538","LU1144417596.USD","LU0237698245.USD","IE00BFSS8Q28.SGD","LU1244550494.USD","LU2264538146.SGD","HRTS","LU0964806797.USD","LU1051770623.HKD","LU1221951046.USD","LU0345768740.USD","SG9999014880.SGD","BK4602","LU1564329032.USD","LU0106261372.USD","BK4077","LU1066053197.SGD","LU2168564149.EUR","LU0302445910.USD","LU1003077747.HKD","LU1868836914.USD","IE00BZ08YR35.GBP","LU2091194634.USD","LU1019634622.SGD","NVII","LU2237957902.USD","LU0640478417.SGD","LU2360108059.USD","LU1032466523.USD","LU1400636657.SGD","PAWZ","07788","IE0004445015.USD","RXL","LU2298321311.HKD","LU2097829019.USD","IE000M9KFDE8.USD","LU1064131342.USD","FTXH","LU1064927863.SGD","LU0143551892.USD","OGIG","BK4561","OZEM","SPTE","LU2039709279.SGD","SG9999014575.USD","BK4514","LU1104425308.USD","IE00BDGV0183.EUR","LU0215105999.USD","LU0648001328.SGD","LU2210150020.SGD","LU2293690249.USD","LU0859254822.USD","SG9999015986.USD","BK4568","LU0211328371.USD","LU1084165304.USD","LU1267930490.SGD","LU0957808578.USD","SGXZ80539844.SGD","LU0162691827.USD","LU1883839398.USD","LU0894486033.HKD","LU0048573561.USD","AZN.UK","BK4554","LU1152091168.USD","IE00B19Z9505.USD","IE000W1ABFV2.USD","LU2065171402.SGD","LU0823421416.USD","IE00BK4W5M84.HKD","LU2381873111.SGD","LU2491050071.SGD","SG9999014914.USD","IE00B7SZL793.SGD","LU0784383803.USD","LU0203201768.USD","IE0004091025.USD","LU1935043536.SGD","IXJ","NVYY","LU1188199696.SGD","IE000F7OJYX1.SGD","FDTX","IE000WAW04H5.SGD","IE00BHPRN162.USD","02228","LU1323610961.USD","LU1400636574.HKD","LU1582987324.SGD","LU2089284900.SGD","LU0708995401.HKD","IE00B775SV38.USD","LU2097344357.USD","LU1863844749.USD","HK0000914686.HKD","LU2106854487.HKD","LU1935043023.USD","IE00BJJMRX11.SGD","LU1935042488.USD","LU2100268510.USD","USD","BK4535","BK1515","IE00BVYPNV92.GBP","LU2108987350.USD","GLAM","LU2756315318.SGD","LU1119994496.HKD","LU1880398471.USD","LU0133085943.USD","LU1564329628.SGD","LU2347655073.USD","01093","LU0306807586.USD","LU0466842654.USD","LU0980610538.SGD","LU1366192091.USD","LU2242652126.USD","LU2552382058.USD","ARTY","LU0314104364.USD","VHT","LU2764262908.HKD","LU1032955483.USD","LU2462591277.SGD","KURE","CQTM","BK1191","IE00B7KXQ091.USD","LU2361044949.HKD","LU2637965513.SGD","MEDI","LU0784384876.USD","BK4007","IE00BZ08YS42.EUR","LU0006061336.USD","LU1116320737.USD","LU1170363599.USD","LU2463028550.USD","BK4529","LU2413666426.HKD","IE00B1XK9C88.USD","LU0827474353.SGD","LU0880133367.SGD","LU1228905037.USD","LU1035775433.USD","LU2357125470.USD","LU0096364046.USD","LU0256863811.USD","LU0130518102.USD","LU2505996681.GBP","IE0031619046.USD","BK4533","IE00B3SWFQ91.USD","FTEC","LU0471298777.SGD","LU1571399168.USD","LU1861220033.SGD","ILDR","LU2077746001.SGD","LU0238689110.USD","LU0130103400.USD","LU0499090636.EUR","LU2242649171.HKD","IE00BMPRXR70.SGD","LU0894485498.HKD","LU0109392836.USD","IE00B775H168.HKD","IE00BZ199S13.USD","LU2506951792.HKD","LU0683600562.USD","IE00BDCRKT87.USD","SG9999015945.SGD","LU0320765992.SGD","HK0000165453.HKD","LU0345770993.USD","HEAL","LU2357305700.SGD","IE000SO60NU8.SGD","TRFK","LU2111349929.HKD","THMR","LU1791710582.SGD","LU1670756490.USD","IE00B4R5TH58.HKD","IE00BJLML261.HKD","LU0320765646.SGD","LU2095319765.USD","LU0011850046.USD","SG9999001077.SGD","LU1992135399.USD","IE0034235295.USD","IHE","LU0314106906.USD","LU2750360641.GBP","AIFD","NVDB","SG9999015952.SGD","LU1400636491.USD","LU2065171311.SGD","TTXU","NVDW","LU0432979614.USD","LU1989764748.USD","LU0345777659.USD","LU1989763005.USD","LU1993786604.SGD","LU2756315664.SGD","LU0788109477.HKD","LU2430703178.SGD","LU1718418525.SGD","LU0557290698.USD","NVDS","LU1623119135.USD","LU0029874061.USD","LU1242518931.SGD","SMSFTmain","LU0965509101.SGD","SNVD.UK","LU0072462426.USD","LU0047473722.EUR","LU1003076772.USD","IDNA","BK4587","LU1935042991.SGD","BK4581","IE00BFTCPJ56.SGD","GNOM","BK4608","HK0000532082.HKD","LU0920783379.SGD","LU1983299246.USD","ELIL","SG9999018857.SGD","LU0471298694.HKD","LU1066051811.HKD","LU0353189680.USD","LU2083900584.USD","ABFL","LU0868494708.USD","LU0426417589.USD","LU0960925559.SGD","LU0949170772.SGD","LU1894683264.USD","LU0210528500.USD","FAI","HK0000819398.USD","ILMN","SG9999001440.SGD","LU1061106388.HKD","LU0070217475.USD","BK4196","IE00B3S45H60.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488857","title":"One Nation staffer allegedly assaulted at major Australian show‘They were spat on. They were punched.’3 min read","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488857","media":"7NEWS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660488857?lang=en_us&edition=fundamental","pubTime":"2026-08-17 00:00","pubTimestamp":1786896000,"startTime":"0","endTime":"0","summary":"A One Nation staffer has been hospitalised with a broken rib after she was allegedly attacked while wearing One Nation-branded clothing at a major Australian agricultural show.The woman, who is in her","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"7news_stock","url":"https://7news.com.au/news/one-nation-staffer-hospitalised-after-alleged-attack-at-brisbane-ekka-c-22736221","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://7news.com.au/news/one-nation-staffer-hospitalised-after-alleged-attack-at-brisbane-ekka-c-22736221","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"7news_stock","symbols":["IOZ.AU","GIVE.AU","BK4585","QRE.AU","VAP.AU","STW.AU","BBOZ.AU","RNA","SLF.AU","VAS.AU","QFN.AU","OZR.AU","BK4505","IISV.AU","DACE.AU","XKO.AU","IMLC.AU","BK4588","IE0009354923.USD","BEAR.AU","ZYAU.AU","GEAR.AU","EIGA.AU","IIGF.AU","OZF.AU","BK4139","XAO.AU","XJO.AU","E200.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659839125","title":"Atrium Therapeutics Price Target Maintained with a $25.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659839125","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659839125?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:37","pubTimestamp":1786729020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNA/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659127634","title":"The huge change set to reshape a beloved Australian traditionNew arenas, homes and facilities are coming to a historic precinct with a 150-year legacy.3 min read","url":"https://stock-news.laohu8.com/highlight/detail?id=2659127634","media":"7NEWS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659127634?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:00","pubTimestamp":1786723200,"startTime":"0","endTime":"0","summary":"As the final Ekka crowds leave the Brisbane showgrounds on Sunday night, demolition crews will move in within days, marking the beginning of a major transformation of the historic precinct.Within a week of the Royal Queensland Show wrapping up its 150th exhibition, the old Machinery Hill stand, Stockman’s Bar and some horse stalls will be demolished, making way for a new 20,000-seat main arena, a new horse pavilion and a rebuilt grandstand.WATCH THE VIDEO ABOVE: What happens to the Brisbane Showgrounds after the Ekka?“We know we’re here for a very small time in the history of the RNA and, you know, in two years’ time or thereabouts, we’ll open the gates for the Ekka and people will see these new facilities and then, of course, we’ll be well and truly","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"7news_stock","url":"https://7news.com.au/news/ekka-2026-brisbane-showgrounds-set-for-more-than-280m-transformation-ahead-of-2032-olympics-c-22720481","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://7news.com.au/news/ekka-2026-brisbane-showgrounds-set-for-more-than-280m-transformation-ahead-of-2032-olympics-c-22720481","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"7news_stock","symbols":["GIVE.AU","XJO.AU","SLF.AU","E200.AU","IISV.AU","DACE.AU","XAO.AU","IMLC.AU","QFN.AU","XKO.AU","RNA","VAS.AU","ZYAU.AU","OZF.AU","EIGA.AU","IOZ.AU","BK4585","BK4139","QRE.AU","GEAR.AU","BEAR.AU","STW.AU","OZR.AU","IE0009354923.USD","BK4588","IIGF.AU","BK4505","VAP.AU","BBOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659741143","title":"Atrium Therapeutics, Inc. (RNA) Receives a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2659741143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659741143?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:56","pubTimestamp":1786705004,"startTime":"0","endTime":"0","summary":"In a report released today, Yanan Zhu from Wells Fargo maintained a Buy rating on Atrium Therapeutics, Inc., with a price target of $25.00. Zhu cov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/atrium-therapeutics-inc-rna-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/atrium-therapeutics-inc-rna-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0314106906.USD","LU1267930227.SGD","IE00B7SZLL34.SGD","LU0251142724.SGD","LU0310799852.SGD","LU2461242641.AUD","LU0980610538.SGD","LU0310800379.SGD","LU0211327993.USD","LU0648001328.SGD","IYF","LU0154236417.USD","LU0310800965.SGD","BK4207","BK4588","LU2361044865.SGD","LU0052756011.USD","BK4505","LU0072461881.USD","PGF","RNA","LU0868494708.USD","LU0149725797.USD","LU0048573561.USD","LU1668664300.SGD","LU0130102774.USD","LU1035773651.USD","LU0162691827.USD","TFNS","LU0971096721.USD","LU0289960550.SGD","LU0640476718.USD","FTXO","LU0029864427.USD","LU1814569148.SGD","LU2361044949.HKD","LU1069347547.HKD","LU0208291251.USD","IE00B19Z3581.USD","LU0787776722.HKD","IE0009354923.USD","BK4504","LU0683600562.USD","LU1791807156.HKD","BK4559","IE0002270589.USD","LU1363072403.SGD","KBWB","LU1506573853.SGD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659193899","title":"Heart Drug Developer Atrium Therapeutics' Q2 Loss Widens as Expenses Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2659193899","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659193899?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:46","pubTimestamp":1786657566,"startTime":"0","endTime":"0","summary":"Heart drug developer Atrium Therapeutics' Q2 loss widens as expenses riseOverviewU.S. biopharmaceutical firm's Q2 collaboration revenue fell yr/yr as R&D services declinedCompany posted wider net loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A1BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU1093756168.USD","LU1670710588.SGD","KOD","IE00BJT1NW94.SGD","LU0237698245.USD","ENSC","LU0456855351.SGD","LU1323610961.USD","IE0002141913.USD","FTXH","BK4007","RNA","LU1670710661.SGD","IE00BFXG1179.USD","BMY","BK4585","LU0882574055.USD","IE00B2B36J28.USD","BK4139","IE00BJJMRZ35.SGD","LU0225284248.USD","LU1883839398.USD","LU1093756325.SGD","LU0432979614.USD","LU1718418525.SGD","LU1868836591.USD","BK4534","LU0868494617.USD","LU2125154778.USD","LU0306806265.USD","BK4532","LU1032466523.USD","LU1989771016.USD","LU1983299246.USD","IE0009354923.USD","LU1074936037.SGD","BK4588","LU1291159041.SGD","LU2242652126.USD","LU1571399168.USD","LU1868837300.USD","BK4505","LU0985481810.HKD","LU1868836757.USD","LU1430594728.SGD","BK4559","LU1868836914.USD","LU2596442595.SGD","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659019878","title":"Atrium Therapeutics Q2 Basic EPS USD -1.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2659019878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659019878?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:37","pubTimestamp":1786657027,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLX0GX54X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","BK4588","BK4585","RNA","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659198880","title":"Atrium Therapeutics Posts Investor Presentation on Precision RNA Medicines for Cardiac Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2659198880","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659198880?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:08","pubTimestamp":1786655292,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics posts investor presentation on precision RNA medicines for cardiac diseaseAtrium Therapeutics highlighted ATR1072, an RNA-targeting program for PRKAG2 syndrome, a genetic cardiomyo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2RDfQ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4588","BK4139","RNA","IE0009354923.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659930160","title":"Atrium Therapeutics Posts Q2 R&D Expense of $15.3 Million on Trial Prep, IND-Enabling Work","url":"https://stock-news.laohu8.com/highlight/detail?id=2659930160","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659930160?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:54","pubTimestamp":1786654482,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics posts Q2 R&D expense of $15.3 million on trial prep, IND-enabling workFDA cleared the IND for ATR 1072, enabling Corventis, a Phase 1/2 trial in PRKAG2 syndrome.Health Canada issue","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2tMpkd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4139","IE0009354923.USD","RNA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659116062","title":"Atrium Therapeutics Q2 FY26 Net Loss Widens to $20.19 Million; Revenue Falls to $3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659116062","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659116062?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:51","pubTimestamp":1786654307,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics Q2 FY26 net loss widens to $20.19 million; revenue falls to $3 millionAtrium Therapeutics posted a Q2 net loss of $20.19 million, widening from $12.88 million a year earlier.Collab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL8Y5ltK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4588","BK4585","BK4139","RNA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659606401","title":"Atrium Therapeutics Q2 EPS $(1.18) Misses $(1.01) Estimate, Sales $3.004M Beat $2.000M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659606401","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659606401?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:49","pubTimestamp":1786654166,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics (NASDAQ:RNA) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of $(1.01) by 16.83 percent. This is a 2.48 percent increase over losses of $(1.21) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61195861/atrium-therapeutics-q2-eps-1-18-misses-1-01-estimate-sales-3-004m-beat-2-000m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Atrium Therapeutics Q2 EPS $(1.18) Misses $(1.01) Estimate, Sales $3.004M Beat $2.000M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169165","title":"Atrium Therapeutics, Inc. (RNA) Receives a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169165?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:15","pubTimestamp":1786641334,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Atrium Therapeutics, Inc. today and set a price target of $25.00. According to T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/atrium-therapeutics-inc-rna-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/atrium-therapeutics-inc-rna-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","IE0009354923.USD","BK4588","BK4505","RNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659512891","title":"Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2659512891","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659512891?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:00","pubTimestamp":1786622411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA53QBVJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BSNM7G36.USD","IE0009355771.USD","LU1093756168.USD","LU1670710588.SGD","IE00BJT1NW94.SGD","LU0237698245.USD","LU0456855351.SGD","LU1670711040.USD","IE0002141913.USD","FTXH","BK4007","LU2360032135.SGD","RNA","LU1670710661.SGD","IE00BFXG1179.USD","BMY","LU0225771236.USD","BK4581","LU0882574055.USD","BK4139","LU0225284248.USD","LU1261432733.SGD","LU1883839398.USD","LU1718418525.SGD","LU0432979614.USD","LU2125154778.USD","BK4534","LU0306806265.USD","BK4532","LU0114720955.EUR","LU1032466523.USD","LU1989771016.USD","LU1983299246.USD","BK4588","LU1291159041.SGD","LU2242652126.USD","LU1571399168.USD","LU2133065610.SGD","LU1868837300.USD","LU0306807586.USD","LU1868837136.USD","LU0321505439.SGD","LU1430594728.SGD","LU1868836757.USD","BK4559","LU2125154935.USD","LU1868836914.USD","LU2242646821.SGD","IHE","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atriumtherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0371},{"period":"1month","weight":0.2167},{"period":"3month","weight":0.0754},{"period":"6month","weight":-0.0522},{"period":"1year","weight":-0.2233},{"period":"ytd","weight":-0.2233}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0408},{"period":"3month","weight":0.0193},{"period":"6month","weight":0.1241},{"period":"1year","weight":0.1925},{"period":"ytd","weight":0.1308}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease is under phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of Duchenne Muscular Dystrophy, which is under phase 1/2 clinical trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy is in phase 1/2 clinical trial. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.025613},{"month":2,"riseRate":0.666667,"avgChangeRate":0.084173},{"month":3,"riseRate":0.4,"avgChangeRate":-0.00029},{"month":4,"riseRate":0.4,"avgChangeRate":-0.058331},{"month":5,"riseRate":0.4,"avgChangeRate":-0.018927},{"month":6,"riseRate":0.8,"avgChangeRate":0.113151},{"month":7,"riseRate":0.5,"avgChangeRate":0.027674},{"month":8,"riseRate":0.666667,"avgChangeRate":0.073003},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.048121},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.000506},{"month":11,"riseRate":0.666667,"avgChangeRate":0.096576},{"month":12,"riseRate":0.666667,"avgChangeRate":0.110632}],"exchange":"NASDAQ","name":"Atrium Therapeutics","nameEN":"Atrium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atrium Therapeutics(RNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Atrium Therapeutics(RNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Atrium Therapeutics,RNA,Atrium Therapeutics股票,Atrium Therapeutics股票老虎,Atrium Therapeutics股票老虎国际,Atrium Therapeutics行情,Atrium Therapeutics股票行情,Atrium Therapeutics股价,Atrium Therapeutics股市,Atrium Therapeutics股票价格,Atrium Therapeutics股票交易,Atrium Therapeutics股票购买,Atrium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atrium Therapeutics(RNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Atrium Therapeutics(RNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction